Latest News for: interleukin-6

Edit

Interleukin-2 (IL-2) Market to Grow Rapidly Over the Next Decade by 2034, DelveInsight Observes | ...

GetNews 30 Jan 2026
"Interleukin-2 Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" ... The Interleukin-2 (IL-2) market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period.
Edit

Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody

PR Newswire 10 Dec 2025
... the first participant has been successfully dosed in a Phase 1 clinical trial of IBI3011, an anti-human Interleukin 1 receptor accessory protein (IL-1RAP) monoclonal antibody developed by Innovent.
Edit

Correlation between Interleukin (IL)-8 and Tumor Necrosis Factor (TNF)-Alpha Levels and Overall Survival in Patients (Pts) with Myelofibrosis (MF) Relapsed or Refractory (R/R) to a Janus-Associated Kinase Inhibitor (JAKi) Treated with Imetelstat (IME) in the IMbark Trial (Geron Corporation)

Public Technologies 08 Dec 2025
C, cycle; D, day; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; ITAC, interleukin-1 receptor-associated kinase 1; MIP, macrophage inflammatory protein; TNF-α, tumor necrosis factor alpha.
Edit

Interleukin-6 (IL-6) Receptor Antagonists and IL6- Inhibitors Competitive Intelligence Report 2025: Launch of the First ...

Nasdaq Globe Newswire 27 Nov 2025
.
Edit

Dynamics and variegation in the Treg response to Interleukin-2

PNAS 20 Nov 2025
By analyzing mRNA and chromatin responses to IL2 in ... .
  • 1

Article Search

tools
×
×
×
×